This is in contrast to fructose-induced rat and murine models of NAFLD, where the main targets of SREBP-1c-mediated transactivation, Acaca and Fasn, were upregulated 6- to 16-fold compared to a control animal [22,51]. The gene discussed is FASN; the disease is metabolic dysfunction-associated steatotic liver disease.